Why the study?
Does doxorubicin treatment cause early changes in left atrial function and global longitudinal strain in patients with preserved LVEF?
Cohort (n=61)
No
Does doxorubicin treatment cause early changes in left atrial function and global longitudinal strain in patients with preserved LVEF?
Real-time 3D echocardiography can detect early subclinical left atrial functional changes and reduced global longitudinal strain in patients receiving doxorubicin, even when LVEF remains preserved.
Answers are grounded in this paper and cite their sources.
Suggests subclinical left atrial dysfunction precedes LVEF decline during anthracycline therapy; leaves.
Real-time three-dimensional echocardiography(RT-3DE) has allowed a better assessment of LA volumes and function. We sought to assess the early change in left atrial size and function in patients treated with anthracyclines using RT-3DE. 61 patients aged 44.9 ± 11.9 years with large B-cell non-Hodgkin lymphoma treated with doxorubicin were studied. Blood collection and echocardiography were performed at baseline and 1 day after completion of the chemotherapy. Global longitudinal strain (GLS), maximum, minimum and pre-atrial contraction LA volumes were measured and reservoir, conduit and booster pump function were assessed. Despite normal LVEF, passive emptying percent of total emptying (0.51 ± 0.14 vs. 0.40 ± 0.12, P < 0.001) and passive emptying index (0.29 ± 0.10 vs. 0.23 ± 0.06, P < 0.001) were remarkably reduced compared to baseline values, while active emptying percent of total emptying (0.49 ± 0.14 vs. 0.60 ± 0.12, P < 0.001) and active emptying index (0.41 ± 0.16 vs. 0.47 ± 0.16, P = 0.048) were increased. GLS (-21.64 ± 2.83 vs. -17.30 ± 2.50) was markedly reduced, cTnT levels was elevated from 0.005 ± 0.004 to 0.020 ± 0.026 ng/mL at the completion of chemotherapy (P all < 0.001). Early LA functional change occur after doxorubicin exposure in patients with preserved LVEF, which could be detected by RT-3DE.
No takes yet. Share an insight, caveat, or question.
Shi et al. (2016) conducted a cohort in Large B-cell non-Hodgkin lymphoma (n=61). Doxorubicin (R-CHOP regimen) vs. Baseline (before chemotherapy) was evaluated on Passive emptying percent of total emptying (PE) (p=<0.001).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: